{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:03:01Z","timestamp":1775221381292,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.7759\/cureus.106363","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:06:55Z","timestamp":1775218015000},"source":"Crossref","is-referenced-by-count":0,"title":["Thanatophoric Dysplasia Type I Confirmed by Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation: Clinical Course and Ethical Considerations"],"prefix":"10.7759","author":[{"given":"Maria  I","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Ver\u00edssimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel A","family":"Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Mar\u00e7al","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Approach to prenatal diagnosis of life-limiting skeletal dysplasias. (2025). Accessed. December 5, 2025: https:\/\/www.uptodate.com\/contents\/approach-to-prenatal-diagnosis-of-life-limiting-skeletal-dysplasias."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4066","article-title":"Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA","volume":"33","author":"Chitty LS","year":"2013","unstructured":"Chitty LS, Khalil A, Barrett AN, Pajkrt E, Griffin DR, Cole TJ. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenat Diagn. 2013, 33:416-23. 10.1002\/pd.4066","journal-title":"Prenat Diagn"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3056324","article-title":"Thanatophoric dysplasia: a report of 2 cases with antenatal misdiagnosis","volume":"2022","author":"Audu L","year":"2022","unstructured":"Audu L, Gambo A, Baduku TS, Farouk B, Yahaya A, Jacob K. Thanatophoric dysplasia: a report of 2 cases with antenatal misdiagnosis. Case Rep Pediatr. 2022, 2022:3056324. 10.1155\/2022\/3056324","journal-title":"Case Rep Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2727.141513","article-title":"Thanatophoric dysplasia type I: a rare case report at fetal autopsy","volume":"6","author":"Davanageri RS","year":"2014","unstructured":"Davanageri RS, Shokeen PD, Bannur HB, Patil KP. Thanatophoric dysplasia type I: a rare case report at fetal autopsy. J Lab Physicians. 2014, 6:121-3. 10.4103\/0974-2727.141513","journal-title":"J Lab Physicians"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0223(200102)21:2<89::aid-pd21>3.0.co;2-9","article-title":"Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia","volume":"21","author":"Chen CP","year":"2001","unstructured":"Chen CP, Chern SR, Shih JC, et al.. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenat Diagn. 2001, 21:89-95. 10.1002\/1097-0223(200102)21:2&lt;89::aid-pd21&gt;3.0.co;2-9","journal-title":"Prenat Diagn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.1.0387","article-title":"The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans","volume":"21","author":"Vajo Z","year":"2000","unstructured":"Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev. 2000, 21:23-39. 10.1210\/edrv.21.1.0387","journal-title":"Endocr Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320280521","article-title":"Thanatophoric dysplasia and cloverleaf skull","volume":"3","author":"Langer LO Jr","year":"1987","unstructured":"Langer LO Jr, Yang SS, Hall JG, Sommer A, Kottamasu SR, Golabi M, Krassikoff N. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl. 1987, 3:167-79. 10.1002\/ajmg.1320280521","journal-title":"Am J Med Genet Suppl"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/uog.13337","article-title":"Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia","volume":"44","author":"Wang DC","year":"2014","unstructured":"Wang DC, Shannon P, Toi A, et al.. Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia. Ultrasound Obstet Gynecol. 2014, 44:588-94. 10.1002\/uog.13337","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-999794","article-title":"Prepartum diagnosis of limb-shortening defects with associated hydramnios","volume":"4","author":"Thomas RL","year":"1987","unstructured":"Thomas RL, Hess LW, Johnson TR. Prepartum diagnosis of limb-shortening defects with associated hydramnios. Am J Perinatol. 1987, 4:293-9. 10.1055\/s-2007-999794","journal-title":"Am J Perinatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/uog.11127","article-title":"Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound","volume":"40","author":"Blaas HG","year":"2012","unstructured":"Blaas HG, Vogt C, Eik-Nes SH. Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound. Ultrasound Obstet Gynecol. 2012, 40:230-4. 10.1002\/uog.11127","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/13201.6702","article-title":"Thanatophoric dysplasia: a case report","volume":"9","author":"Sharma M","year":"2015","unstructured":"Sharma M, Jyoti, Jain R, Devendra. Thanatophoric dysplasia: a case report. J Clin Diagn Res. 2015, 9:QD01-3. 10.7860\/JCDR\/2015\/13201.6702","journal-title":"J Clin Diagn Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32485","article-title":"The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US","volume":"146A","author":"Waller DK","year":"2008","unstructured":"Waller DK, Correa A, Vo TM, et al.. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A. 2008, 146A:2385-9. 10.1002\/ajmg.a.32485","journal-title":"Am J Med Genet A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.37.220.21211","article-title":"Thanatophoric dysplasia: a case report","volume":"37","author":"Jagun OE","year":"2020","unstructured":"Jagun OE, Olusola-Bello MA, Adekanmbi AF, Jagun OO, Oduwole T. Thanatophoric dysplasia: a case report. Pan Afr Med J. 2020, 37:220. 10.11604\/pamj.2020.37.220.21211","journal-title":"Pan Afr Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/pmr.2020.0016","article-title":"Should we stop calling thanatophoric dysplasia a lethal condition? A case report of a long-term survivor","volume":"1","author":"Carroll RS","year":"2020","unstructured":"Carroll RS, Duker AL, Schelhaas AJ, Little ME, Miller EG, Bober MB. Should we stop calling thanatophoric dysplasia a lethal condition? A case report of a long-term survivor. Palliat Med Rep. 2020, 1:32-9. 10.1089\/pmr.2020.0016","journal-title":"Palliat Med Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","author":"Fenton TR","year":"2013","unstructured":"Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013, 13:59. 10.1186\/1471-2431-13-59","journal-title":"BMC Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"Passos-Bueno MR","year":"1999","unstructured":"Passos-Bueno MR, Wilcox WR, Jabs EW, et al.. Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat. 1999, 14:115-25. 10.1002\/(SICI)1098-1004(1999)14:2&lt;115::AID-HUMU3&gt;3.0.CO;2-2","journal-title":"Hum Mutat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2017.02.019","article-title":"Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation","volume":"102","author":"Jung M","year":"2017","unstructured":"Jung M, Park SH. Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation. Exp Mol Pathol. 2017, 102:290-5. 10.1016\/j.yexmp.2017.02.019","journal-title":"Exp Mol Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.29","article-title":"Growth and development in thanatophoric dysplasia - an update 25\u00a0years later","volume":"1","author":"Nikkel SM","year":"2013","unstructured":"Nikkel SM, Major N, King WJ. Growth and development in thanatophoric dysplasia - an update 25\u00a0years later. Clin Case Rep. 2013, 1:75-8. 10.1002\/ccr3.29","journal-title":"Clin Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5455\/2320-6012.ijrms20140830","article-title":"Antenatal diagnosis of thanatophoric dysplasia: a case report and review of literature","volume":"2","author":"Kocherla K","year":"2014","unstructured":"Kocherla K, Kocherla V. Antenatal diagnosis of thanatophoric dysplasia: a case report and review of literature. Int J Res Med Sci. 2014, 2:1176-9. 10.5455\/2320-6012.ijrms20140830","journal-title":"Int J Res Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464211-thanatophoric-dysplasia-type-i-confirmed-by-fibroblast-growth-factor-receptor-3-fgfr3-mutation-clinical-course-and-ethical-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:06:55Z","timestamp":1775218015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464211-thanatophoric-dysplasia-type-i-confirmed-by-fibroblast-growth-factor-receptor-3-fgfr3-mutation-clinical-course-and-ethical-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.106363","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}